Centro de Estudios Clínicos SAGA

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Lung cancer2 trials
• Bladder cancer1 trial
• Cervical cancer1 trial
• Endometrial cancer1 trial
• Gastric and oesophageal cancer1 trial
• Head and neck cancer1 trial
• Myeloproliferative neoplasms1 trial
• Ovarian cancer1 trial

Phase

• Phase 32 trials
• Phase 1/21 trial

Status

• Active, not recruiting2 trials
• Recruiting1 trial

Lead sponsor

• Boehringer Ingelheim1 trial
• Klus Pharma Inc.1 trial
• Protagonist Therapeutics, Inc.1 trial

Running trials

• Recruiting

  Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations

  NCT07195695· Phase 3· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

• Active, not recruiting

  A Study of Rusfertide in Adults With Polycythemia Vera (PV)

  NCT05210790· Phase 3· Protagonist Therapeutics, Inc.· Source

• Active, not recruiting

  Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01)

  NCT04152499· Phase 1/2· Klus Pharma Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer1 recruiting